Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2
- 1 February 1990
- Vol. 8 (1) , 17-21
- https://doi.org/10.1016/0264-410x(90)90171-h
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDSNature, 1988
- Prevention of vaccinia virus infection in imiminodeficient mice by vector-directed IL-2 expressionNature, 1987
- Vaccinia Virus Expression VectorsAnnual Review of Immunology, 1987
- Immunization against AIDS in humansNature, 1987
- Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) DiseaseNew England Journal of Medicine, 1987
- Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strainVaccine, 1987
- Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated LymphocytesAnnual Review of Immunology, 1986
- Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotypeNature, 1985
- Immunization with antigen and interleukin 2 in vivo overcomes Ir gene low responsiveness.The Journal of Experimental Medicine, 1985
- Live recombinant vaccinia virus protects chimpanzees against hepatitis BNature, 1984